Response to Science and Technology’s report
7 February 2005
“We welcome the Committee’s recognition of the MRC’s responsibility to carry out periodic reviews of its major institutes.”
“The review of NIMR has been unusually complex and we welcome the Committee’s view that it was fair and that ‘any shortcomings were not so serious as to invalidate the outcome.’
“MRC Council is actively pursuing implementation of its vision for the renewed Institute in Central London, as endorsed by the Committee. The Council will be considering its choice of partner institution at its meeting later this week. The intention is that MRC and the staff at NIMR will then move forward with the preferred partner to develop the full business case.”
MRC Chairman Sir Anthony Cleaver
A further announcement will be made on Friday 11 February.
Notes to editors
The Medical Research Council (MRC) is a national organisation funded by the UK tax-payer. Its business is medical research aimed at improving human health; everyone stands to benefit from the outputs. The research it supports and the scientists it trains meet the needs of the health services, the pharmaceutical and other health-related industries and the academic world. MRC has funded work which has led to some of the most significant discoveries and achievements in medicine in the UK. About half of the MRC’s expenditure of £450 million is invested in its 40 Institutes, Units and Centres. The remaining half goes in the form of grant support and training awards to individuals and teams in universities and medical schools.
